BPO bioprospect limited

racing

  1. 2,176 Posts.
    Looks like a good time to get in to me.

    Check the SLA presentation.

    Equine Gastric Ulcer Syndrome. Solagran and BioProspect have been approached
    recently by thoroughbred owners from the Middle East interested in the potential of
    Bioeffectives A and I to be used in combination as a treatment for EGUS, a condition
    endemic in the racing industry worldwide.
    If adopted, this could translate into a demand of 7g of Bioeffective A per day per animal
    (equivalent to more than two packs of Bioeffective A 320 every three days)

    I don't own BPO ATM
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.